CMP Therapeutics develops chitin microparticles for macrophages and dendritic cells in the nasal and respiratory tract.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Welwyn Garden City
State: Hertford
Zip:
Country: United Kingdom
CMP Therapeutics, Ltd., a biopharmaceutical company, develops chitin microparticles (CMP) for macrophages and dendritic cells in the nasal and respiratory tract. The company develops a CMP nasal spray for the treatment of allergic rhinitis, as well as for the clinical applications of nasal spray for enhancing natural resistance to influenza and other respiratory pathogens. Its CMP is also used as an adjuvant in nasal vaccines. The company was founded in 2004 and is based in Bicester, the United Kingdom.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2006 | Series A | 1 | $5.7M |
Inventages Venture Capital Investment Inc. Inventages Venture Capital Investment Inc. |
7/2010 | Venture Round | 1 | $2M |
Inventages Venture Capital Investment Inc. Inventages Venture Capital Investment Inc. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|